Inventor · disambiguated record
Patrick Burke
Also filed as: BURKE PATRICK · BURKE PATRICK J
26 granted patents·16 pending applications·508 citations·filing 2004–2024
97Inventor score
Top patents by PatentIndex Score
42 records- 0198US9713647B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 25, 2017·26 cites·10 claims
- 0298US8697688B2Pyrrolobenzodiazepines used to treat proliferative diseasesHOWARD PHILIP WILSON·Filed 2011·Granted Apr 15, 2014·155 cites·7 claims
- 0397US9242013B2Targeted pyrrolobenzodiazapine conjugatesHOWARD PHILIP WILSON·Filed 2011·Granted Jan 26, 2016·78 cites·41 claims
- 0496US9592240B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Mar 14, 2017·23 cites·11 claims
- 0596US9526798B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Dec 27, 2016·21 cites·4 claims
- 0696US8163551B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2009·Granted Apr 24, 2012·48 cites·64 claims
- 0795US9707301B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 18, 2017·21 cites·10 claims
- 0894US9387259B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Jul 12, 2016·24 cites·22 claims
- 0993US9816069B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2015·Granted Nov 14, 2017·6 cites·20 claims
- 1093US8993326B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2013·Granted Mar 31, 2015·9 cites·20 claims
- 1192US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 1292US9399073B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·24 cites·17 claims
- 1391US8574907B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2012·Granted Nov 5, 2013·19 cites·27 claims
- 1488US11319526B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2019·Granted May 3, 2022·2 cites·63 claims
- 1588US10561739B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Feb 18, 2020·4 cites·22 claims
- 1687US10443035B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2017·Granted Oct 15, 2019·2 cites·12 claims
- 1786US11103593B2Pegylated drug-linkers for improved ligand-drug conjugate pharmacokineticsSEAGEN INC·Filed 2014·Granted Aug 31, 2021·13 cites·26 claims
- 1886US9587019B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2013·Granted Mar 7, 2017·7 cites·28 claims
- 1983US11116847B2Methylene carbamate linkers for use with targeted-drug conjugatesSEAGEN INC·Filed 2014·Granted Sep 14, 2021·3 cites·53 claims
- 2083US10328084B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Jun 25, 2019·1 cites·15 claims
- 2180US2023055475A1Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2022·Application pending·0 cites
- 2278US10787514B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2017·Granted Sep 29, 2020·1 cites·24 claims
- 2377US11819553B2Glypican 3 antibodies and conjugates thereofSEAGEN INC·Filed 2019·Granted Nov 21, 2023·1 cites·21 claims
- 2477US2024325561A1Pegylated drug-linkers for improved ligand-drug conjugate pharmacokineticsSEAGEN INC·Filed 2024·Application pending·0 cites
- 2574US11229708B2Conjugates of quaternized tubulysin compoundsSEATTLE GENETICS INC·Filed 2016·Granted Jan 25, 2022·1 cites·28 claims
- 2673US2024247030A1Targeted delivery of tertiary amine-containing drug substancesSEAGEN INC·Filed 2023·Application pending·0 cites
- 2771US2024173427A1Glypican 3 antibodies and conjugates thereofSEAGEN INC·Filed 2023·Application pending·0 cites
- 2868US2021047404A1Cd33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 2965US2022072146A1Pegylated drug-linkers for improved ligand-drug conjugate pharmacokineticsSEAGEN INC·Filed 2021·Application pending·0 cites
- 3064US2024156969A1Conjugates of quaternized tubulysin compoundsSEAGEN INC·Filed 2023·Application pending·0 cites
- 3163US2018228916A1Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 3263US2022054650A1Methylene Carbamate Linkers for use with Targeted-Drug ConjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 3362US2025255981A1Immunomodulatory antibody-drug conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 3462US2024123079A1Immunomodulatory antibody-drug conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 3561US2024261422A1Anthracycline antibody conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 3659US2017143846A1Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 3758US2013309223A1CD33 Antibodies And Use Of Same To Treat CancerSEATTLE GENETICS INC·Filed 2013·Application pending·0 cites
- 3856US11793880B2Conjugates of quaternized tubulysin compoundsSEAGEN INC·Filed 2021·Granted Oct 24, 2023·0 cites·35 claims
- 3955US10329352B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Jun 25, 2019·0 cites·41 claims
- 4050US11938194B2Cysteine mutated antibodies for conjugationSEAGEN INC·Filed 2018·Granted Mar 26, 2024·0 cites·15 claims
- 4147US2017247412A1Targeted delivery of tertiary amine-containing drug substancesSEATTLE GENETICS INC·Filed 2015·Application pending·0 cites
- 4232US2007275911A1Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the SameKOCH TAD H·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick Burke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →